The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
Open accessAbstract
Objective: To assess whether hydroxychloroquine can delay renal damage development in lupus nephritis patients. Methods: Lupus nephritis patients (n = 256) from the LUpus in MInorities, NAture versus nurture study (n = 635), a multiethnic cohort of African Americans, Hispanics, and Caucasians, age ≥16 years with disease duration ≤5 years at baseline (T0) were studied. Renal damage was defined using the Systemic Lupus International Collaborating Clinics Damage Index (≥1 of the following lasting at least 6 months: estimated/measured glomerular filtration rate <50%, 24‐hour proteinuria ≥3.5 gm and/or end‐stage renal disease, regardless of dialysis or transplantation). Patients with renal damage before T0 were excluded (n = 53). The association between hydroxychloroquine use and renal damage (as defined, or omitting proteinuria) was estimated using Cox proportional regression analyses adjusting for potential confounders. Kaplan‐Meier survival curves based on hydroxychloroquine intake or the World Health Organization (WHO) class glomerulonephritis were also derived. Results: Sixty‐three (31.0%) of the 203 patients included developed renal damage over a mean ± SD disease duration of 5.2 ± 3.5 years. The most frequent renal damage domain item was proteinuria. Patients who received hydroxychloroquine (79.3%) exhibited a lower frequency of WHO class IV glomerulonephritis, had lower disease activity, and received lower glucocorticoid doses than those who did not take hydroxychloroquine. After adjusting for confounders, hydroxychloroquine was protective of renal damage occurrence in full (hazard ratio [HR] 0.12, 95% confidence interval [95% CI] 0.02–0.97, P = 0.0464) and reduced (HR 0.29, 95% CI 0.13–0.68, P = 0.0043) models. Omitting proteinuria provided comparable results. The cumulative probability of renal damage occurrence was higher in those who did not take hydroxychloroquine and those classified as WHO class IV glomerulonephritis (P < 0.0001). Conclusion: After adjusting for possible confounding factors, the protective effect of hydroxychloroquine in retarding renal damage occurrence in systemic lupus erythematosus is still evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Self-citationLiang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Gladman, D. D., Urowitz, M. B., Goldsmith, C. H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J. G., Isenberg, D. A., Kalunian, K., Nived, O., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400506 · Cited by 759
Determination of serum creatinine by a direct colorimetric method
Heinegård, D., & Tiderström, G. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90466-x · Cited by 720
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Alarcón, G. S., McGwin, G., Bertoli, A. M., Fessler, B. J., Calvo-Alén, J., Bastian, H. M., Vilá, L. M., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068676 · Cited by 528
Self-citationTLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Baccala, R., Hoebe, K., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2007) · Nature Medicine · doi:10.1038/nm1590 · Cited by 473
Pons-Estel, B. A., Catoggio, L. J., Cardiel, M. H., Soriano, E. R., Gentiletti, S., Villa, A. R., Abadi, I., Caeiro, F., Alvarellos, A., & Alarcón-Segovia, D. (2004) · Medicine · doi:10.1097/01.md.0000104742.42401.e2 · Cited by 447
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data
Austin, H. A., Boumpas, D. T., Vaughan, E. M., & Balow, J. E. (1994) · Kidney International · doi:10.1038/ki.1994.70 · Cited by 407
Fessler, B. J., Alarcón, G. S., McGwin, G., Roseman, J., Bastian, H. M., Friedman, A. W., Baethge, B. A., Vilá, L., Reveille, J. D., & for the LUMINA Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21039 · Cited by 377
Self-citationBastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
Self-citationAlarcón, G. S., Friedman, A. W., Straaton, K. V., Moulds, J. M., Lisse, J., Bastian, H. M., McGwin, G., Bartolucci, A. A., Roseman, J. M., & Reveille, J. D. (1999) · Lupus · doi:10.1191/096120399678847704 · Cited by 309
Self-citationA Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
The Canadian Hydroxychloroquine Study Group, Tsakonas, E., Joseph, L., Esdaile, J. M., Choquette, D., Senécal, J.-L., Cividino, A., Danoff, D., Osterland, C. K., Yeadon, C., et al. (1998) · Lupus · doi:10.1191/096120398678919778 · Cited by 293
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Fernández, M., Alarcón, G. S., Calvo‐alén, J., Andrade, R., McGwin, G., Vilá, L. M., Reveille, J. D., & LUMINA Study Group (2007) · Arthritis Care & Research · doi:10.1002/art.22672 · Cited by 272
Self-citationHydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
Petri, M. (1996) · Lupus · doi:10.1177/0961203396005001051 · Cited by 260
Kasitanon, N., Fine, D. M., Haas, M., Magder, L. S., & Petri, M. (2006) · Lupus · doi:10.1191/0961203306lu2313oa · Cited by 197
Sisó, A., Ramos-Casals, M., Bové, A., Brito-Zerón, P., Soria, N., Muñoz, S., Testi, A., Plaza, J., Sentís, J., & Coca, A. (2008) · Lupus · doi:10.1177/0961203307086503 · Cited by 189
Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking
Ward, M. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.10.2082 · Cited by 184
Gladman, D. D., Goldsmith, C. H., Urowitz, M. B., et al. (1994) · PubMed · Cited by 182
Thrombosis and Systemic Lupus Erythematosus: The Hopkins Lupus Cohort Perspective
Petri, M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069986 · Cited by 176
Gerstein, H. C., Thorpe, K. E., Wayne Taylor, D., & Brian Haynes, R. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00325-4 · Cited by 169
Cervera, R., Khamashta, Font, J., et al. (2003) · Cited by 166
Adler, M., Chambers, S., Edwards, C., Neild, G., & Isenberg, D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel039 · Cited by 163
Biochemical characterization of ADP-ribose polymer metabolism in SLE
Chen, H.-Y., Pertusi, R., Kirkland, J., Rubin, B., & Jacobson, E. (1996) · Lupus · doi:10.1177/096120339600500105 · Cited by 162
Wang, F., Wang, C. L., Tan, C. T., & Manivasagar, M. (1997) · Lupus · doi:10.1177/096120339700600306 · Cited by 158
Antimalarial agents: Closing the gate on toll‐like receptors?
Lafyatis, R., York, M. R., & Marshak‐Rothstein, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22157 · Cited by 153
Clinical Prognostic Factors in Lupus Nephritis
Ward, M. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400220098017 · Cited by 130
Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?
Wallace, D. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301219 · Cited by 124
Chloroquine inhibits proinflammatory cytokine release into human whole blood
Karres, I., Kremer, J.-P., Dietl, I., Steckholzer, U., Jochum, M., & Ertel, W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r1058 · Cited by 124
Petri, M. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70135-6 · Cited by 121
Rivest, C., Lew, R., Welsing, P. M. J., Sangha, O., Wright, E. A., Roberts, W. N., Liang, M. H., & Karlson, E. W. (2000) · PubMed · Cited by 118
Duran-Barragán, S., McGwin, G., Vilá, L. M., Reveille, J. D., & Alarcón, G. S. (2008) · Rheumatology · doi:10.1093/rheumatology/ken208 · Cited by 114
Self-citationDamage accrual in southern Chinese patients with systemic lupus erythematosus.
Mok, C. C., Ho, C. T. K., Wong, R. W. S., & Lau, C. S. (2003) · PubMed · Cited by 86
SLE patients with renal damage incur higher health care costs
Clarke, A. E., Panopalis, P., Petri, M., Manzi, S., Isenberg, D. A., Gordon, C., Senécal, J., Joseph, L., Pierre, Y. S., & Li, T. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem373 · Cited by 82
Predictors of One Year Outcome in Lupus Nephritis: The Importance of Renal Biopsy
Esdaile, J. M., FEDERGREEN, W., QUINTAL, H., SUISSA, S., HAYSLETT, J., & Kashgarian, M. J. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068639 · Cited by 75
Antimalarials—the ‘real‘ advance in lupus
Wallace, D. J. (2001) · Lupus · doi:10.1191/096120301678646092 · Cited by 72
Pilowsky, I. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90123-w · Cited by 71
Chloroquine Extends the Lifetime of the Activated Insulin Receptor Complex in Endosomes
Bevan, A. P., Krook, A., Tikerpae, J., Seabright, P. J., Siddle, K., & Smith, G. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26833 · Cited by 63
Bastian, H. M., Alarcón, G. S., Roseman, J. M., McGwin, G., Vilá, L. M., Fessler, B. J., Reveille, J. D., & for the LUMINA study group (2006) · Rheumatology · doi:10.1093/rheumatology/kel347 · Cited by 59
Self-citationEvidence from Nonrandomized Studies: A Case Study on the Estimation of Causal Effects
Schmoor, C., Caputo, A., & Schumacher, M. C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn010 · Cited by 56
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Bertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M., & Kean, W. F. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0239-y · Cited by 543
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Metadata
- Authors
- Pons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2009-05-28
- Volume
- 61
- Issue
- 6
- Pages
- 830-839
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2015040567
- Cited by
- 306
- References
- 49
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.